Relay Cash from 2010 to 2024

RLAY Stock  USD 7.50  0.36  4.58%   
Relay Therapeutics Cash yearly trend continues to be fairly stable with very little volatility. Cash will likely drop to about 136.5 M in 2024. Cash is the total amount of money in the form of currency that Relay Therapeutics has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2010-12-31
Previous Quarter
143.7 M
Current Value
136.5 M
Quarterly Volatility
256.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Relay Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Relay Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 32.6 M, Interest Income of 32.6 M or Depreciation And Amortization of 4 M, as well as many indicators such as Price To Sales Ratio of 50.19, Dividend Yield of 0.0 or PTB Ratio of 1.0. Relay financial statements analysis is a perfect complement when working with Relay Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Relay Therapeutics Correlation against competitors.
For more information on how to buy Relay Stock please use our How to Invest in Relay Therapeutics guide.

Latest Relay Therapeutics' Cash Growth Pattern

Below is the plot of the Cash of Relay Therapeutics over the last few years. Cash refers to the most liquid asset of Relay Therapeutics, which is listed under current asset account on Relay Therapeutics balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Relay Therapeutics customers. The amounts must be unrestricted with restricted cash listed in a different Relay Therapeutics account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Relay Therapeutics' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Relay Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Very volatile
   Cash   
       Timeline  

Relay Cash Regression Statistics

Arithmetic Mean434,694,680
Geometric Mean350,521,255
Coefficient Of Variation59.03
Mean Deviation146,740,261
Median421,505,000
Standard Deviation256,598,360
Sample Variance65842.7T
Range957M
R-Value0.04
Mean Square Error70776.2T
R-Squared0
Significance0.88
Slope2,469,101
Total Sum of Squares921798.1T

Relay Cash History

2024136.5 M
2023143.7 M
2022998.9 M
2021958.1 M
2020447.6 M
201942 M

Other Fundumenentals of Relay Therapeutics

Relay Therapeutics Cash component correlations

About Relay Therapeutics Financial Statements

Relay Therapeutics investors use historical fundamental indicators, such as Relay Therapeutics' Cash, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Relay Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Relay Stock Analysis

When running Relay Therapeutics' price analysis, check to measure Relay Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relay Therapeutics is operating at the current time. Most of Relay Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relay Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relay Therapeutics' price. Additionally, you may evaluate how the addition of Relay Therapeutics to your portfolios can decrease your overall portfolio volatility.